SHREVEPORT, La. -- Twenty-seven years ago, BRF placed Shreveport on the map as a pioneer in molecular imaging by opening Louisiana’s first positron emission tomography (PET) center. Today, BRF is ...

In the past decade, radiomics, radiogenomics, and nanoparticle-based molecular imaging have become an important focus area of ...

Ronald Blasberg at Memorial Sloan-Kettering Cancer Center, Imaging of gene expression; Harvey Herschman at U. California, Los Angeles, Tracking of gene therapy, gene activities; David Piwnica-Worms at ...

In this interview conducted at Pittcon 2023 in Philadelphia, Pennsylvania, we spoke to Ron Heeren, a speaker at the 2023 James L. Waters Symposium. Please could you introduce yourself, and tell us ...

Siemens Medical Solutions is one of several imaging companies that have jumped into the world of molecular imaging, with a particular focus on systems and biomarkers that work with the brain and ...

In response to the ongoing paradigm shift in how neurodegenerative diseases are defined and diagnosed—as well as the new hope for a breakthrough in disease-modifying drugs—The Journal of Nuclear ...

Bayer bolsters development portfolio by acquisition of two investigational imaging agents (AT-01 and AT-05) from Attralus, Inc. to advance diagnosis for cardiac amyloidosis PET tracer AT-01 in Phase ...

A novel quantitative PET- and MRI-based imaging approach can objectively identify a recently recognized type of dementia--limbic-predominant age-related TDP-43 encephalopathy, or LATE--that is often ...

NEW ORLEANS (June 23, 2025)—The Society of Nuclear Medicine and Molecular Imaging (SNMMI) recognized seven new Fellows today during a plenary session at the society’s 2025 Annual Meeting, held June 21 ...

BERLIN & NAPLES, Fla.--(BUSINESS WIRE)--Bayer, a leading company in key areas of radiology and cardiology, and Attralus, Inc. (Attralus), a clinical stage biopharmaceutical company focused on ...